Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving drugs in different ways may
kill more tumor cells. It is not yet known whether intravenous two-drug combination
chemotherapy is more effective than intravenous and intraperitoneal infusions of three-drug
combination chemotherapy for treating primary peritoneal or stage III epithelial ovarian
cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of intravenous two-drug
combination chemotherapy with intravenous and intraperitoneal three-drug combination
chemotherapy in treating patients who have primary peritoneal or stage III epithelial ovarian
cancer.